In 2020, close to 340 million tons of meat was estimated to be produced worldwide. Compared to the early 1960s (~70 million tons), this represents almost a 500% increase. As a result, raising animals for slaughter is estimated to be responsible for close to 15% of global greenhouse gas emissions. Animal farming also requires large areas of land, for grazing, which is often the cause of deforestation efforts. In this context, it is worth highlighting that raising cattle for beef and lamb meat pro...

In August 2026, 4basebio collaborated with Genezen combining synthetic, cell-free DNA technology with viral-vector manufacturing expertise. Genezen will provide drug developers access to 4basebio’s Research Use Only, high-quality and GMP-grade hpDNA technology as starting material for viral-vector development, clinical programs, and potentially commercial manufacturing.

The women's digital health market is estimated to be worth $2.04 billion in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 18.9% during the forecast period. Females constitute 49.6% of the world

The global aptamers market is estimated to grow from $0.92 billion in 2025 to reach $1.48 billion in 2026 and $12.78 billion by 2035, representing a higher CAGR of 27.0% during the forecast period. Over 100 clinical trials, along with several preclinical studies, have demonstrated the potential of aptamers as a safe and effective treatment modality, owing to their unique characteristics, such as high binding affinity and specificity. Given the various advantages, aptamer-based therapeutics in th...

The report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the treatment of GvHD.

This report provides an in-depth analysis of the product pipeline and developer companies, highlighting the current treatment practices, emerging drugs, and market share of the individual therapies. In addition to other elements, the study includes detailed assessment of the current market landscape, providing information about the product’s mechanism of action, dosage and administration, and pharmacological studies, regulatory milestones, and other development activities.

The report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the treatment of Dravet syndrome.

The “Soft Tissue Sarcoma: Pipeline Review, Developer Landscape and Competitive Insights, 2022-2035” report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the treatment of soft tissue sarcoma.

The report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the treatment of Cryptococcosis.

The “Pompe Disease: Pipeline Review, Developer Landscape and Competitive Insights, 2025-2035” report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the treatment of Pompe Disease.

The “Amnesia: Pipeline Review, Developer Landscape and Competitive Insights, 2022-2035” report features an extensive study on the marketed, clinical and preclinical molecules available / being developed for the treatment of Amnesia.

The pharmaceutical secondary packaging market, valued at $ 7.6 billion in 2025, is projected to grow to $ 8.2 billion in 2026 and $ 16.1 billion by 2035, representing a CAGR of 7.8% during the forecast period. Pharmaceutical secondary packaging is a vital step in the product supply chain as it encloses life-saving drugs and therapies, preserving the identity, quality, integrity and stability of the packaged drug product. It also plays a key role in marketing and brand projection for a product. H...

The viral vaccine cell culture media market, valued at USD 2.5 billion in 2025, is projected to grow to USD 2.7 billion in 2026 and USD 3.4 billion by 2035, representing a CAGR of 2.6% during the forecast period. Over the past few years, a number of advanced vaccines targeting a myriad of disease indications have received approval from various regulatory authorities. Post the onset of COVID-19, there has been a surge in the demand for viral vaccines. In fact, it is estimated that more than 4.5 b...

The global healthcare sector has been overtly reluctant to embrace technology. In August 2026, Royal Philips received USD 33.7 million from ARPA-H to advance AI-enabled robotic stroke care. The program involves Johns Hopkins University and Boston University and will develop technologies for remote, increasingly automated endovascular procedures. 

The global container closure integrity testing market size is estimated to be worth USD 252 million in 2025 and is expected to reach USD 269 million in 2026 and USD 558 million by 2035 at a CAGR of 8.4% during the forecast period. The market for container closure integrity testing (CCIT) is anticipated to witness outstanding growth over this projection time frame. Majorly, continuous advancement in testing methods can be attributed to elevating the market growth. With more than 40 service provi...